Skip to main content

Want a detailed portfolio tracker?

Insmed (INSM) P/E (2011 - 2026)

Insmed (INSM) P/E from Jun 30, 2011 to Jun 3, 2026. The TTM Insmed (INSM) P/E is -18.70. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Insmed (INSM)

YearP/EChange
2026-18.70-33.28%
2025-28.03+119.57%
2024-12.77+113.31%
2023-5.99+8.44%
2022-5.52-22.81%
2021-7.15-36.24%
2020-11.22+39.56%
2019-8.04+157.83%
2018-3.12-69.89%
2017-10.35+75.97%
2016-5.88-34.62%
2015-9.00+4.31%
2014-8.63-20.47%
2013-10.85+136.14%
2012-4.59+170.55%
2011-1.70N/A

Comparison Insmed (INSM) P/E with competitors

Insmed (INSM) P/E is -18.70.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.55%
ENLVEnlivex Therapeutics Ltd0.15-100.80%
FGENFibroGen Inc0.24-101.28%
TRAWTraws Pharma Inc0.47-102.53%
FBIOFortress Biotech Inc0.71-103.77%
CHRSCoherus Biosciences Inc0.98-105.23%
ORMPOramed Pharmaceuticals Inc1.47-107.88%
AGENAgenus Inc2.05-110.95%
VIVSVivoSim Labs Inc2.54-113.56%
INVAInnoviva Inc3.19-117.05%
CRMDCorMedix Inc3.65-119.49%
ABEOAbeona Therapeutics Inc4.20-122.48%
VXRTVaxart Inc4.26-122.78%
CVACCureVac N.V.4.45-123.77%
SRPTSarepta Therapeutics Inc4.62-124.72%
GLPGGalapagos NV4.86-125.98%
RIGLRigel Pharmaceuticals4.92-126.30%
ZVRAZevra Therapeutics Inc4.97-126.59%
ABUSArbutus Biopharma Corp5.69-130.44%
CGENCompugen Ltd7.38-139.48%
AUPHAurinia Pharmaceuticals Inc9.25-149.46%
ACADAcadia Pharmaceuticals Inc9.59-151.26%
OMEROmeros Corporation9.88-152.84%
PLXProtalix BioTherapeutics Inc9.91-152.98%
SPROSpero Therapeutics Inc10.73-157.39%
ADMAAdma Biologics Inc11.33-160.58%
SVASinovac Biotech Ltd11.44-161.14%
TBPHTheravance Biopharma Inc11.78-162.96%
HRMYHarmony Biosciences Holdings Inc12.18-165.12%
TGTXTG Therapeutics Inc13.18-170.46%
INCYIncyte Corp13.38-171.55%
SABSSAB Biotherapeutics Inc14.06-175.16%
XOMAXOMA Corp14.95-179.90%
REGNRegeneron Pharmaceuticals Inc14.98-180.09%
PBYIPuma Biotechnology Inc15.05-180.47%
EXELExelixis Inc15.79-184.45%
NAGENiagen Bioscience Inc16.35-187.44%
CPRXCatalyst Pharmaceuticals Inc17.34-192.73%
MDXGMimedx Group Inc17.38-192.90%
ARGXArgen X SE23.07-223.35%
HALOHalozyme Therapeutics Inc23.20-224.04%
XOMAOXOMA Corp25.34-235.51%
VRTXVertex Pharmaceuticals Inc25.66-237.17%
XOMAPXOMA Corp25.67-237.24%
CTMXCytomX Therapeutics Inc25.70-237.39%
ASNDAscendis Pharma A/S26.35-240.90%
RPRXRoyalty Pharma plc - Class A27.50-247.00%
SLNOSoleno Therapeutics Inc29.02-255.13%
LGNDLigand Pharmaceuticals Inc - Class B30.19-261.39%
BMRNBiomarin Pharmaceutical Inc37.51-300.53%
APLSApellis Pharmaceuticals Inc39.02-308.63%
KRYSKrystal Biotech Inc39.70-312.24%
GMABGenmab40.20-314.95%
ONCBeiGene Ltd67.03-458.36%
TECHBio-Techne Corp68.59-466.74%
VCELVericel Corp80.63-531.08%
PHARPharming Group N.V.87.74-569.10%
ALNYAlnylam Pharmaceuticals Inc124.93-767.96%
TLXTelix Pharmaceuticals Ltd139.89-847.93%
CORTCorcept Therapeutics Inc158.39-946.83%